Christina A. Capacci-Daniel
FDA Investigator
- Christina A. Capacci-Daniel first started conducting FDA inspections in 2014, with the last inspection in 2018. Over that time, Christina A. Capacci-Daniel has conducted 10 inspections at 9 companies across 10 sites.
Get Christina Capacci-Daniel's official FDA inspection documents. Gain valuable insights from their Form 483s and EIRs to ace your next inspection.
Documents
Upon purchase, you will receive an email with a link to immediately download the documents.
FDA 483 Vertex Pharmaceuticals, Inc., Boston | 2017
Out of stock
FDA 483 Baxter Oncology GmbH, Halle (Westf.) | 2017
Out of stock
FDA 483 Janssen Ortho, Llc, Gurabo | 2016
Out of stock
FDA 483 ASM Aerosol Service AG, Mohlin | 2015
Out of stock
FDA 483 Wyeth BioPharma Division of Wyeth Pharmaceuticals, Inc., Andover | 2014
Out of stock
FDA 483 Impax Laboratories (Taiwan) Inc., Jhunan, Miao-Li County | 2014
Out of stock
FDA 483 Impax Laboratories (Taiwan) Inc., Jhunan, Miao-Li County | 2014
Out of stock
Co-Investigators (16)
- Sean R. Marcsisin, FDA Investigator
- Sharmista Chatterjee, FDA Investigator
- Yong Hu, FDA Investigator
- Dennis Cantellops Paite, FDA Investigator
- Kumar G. Janoria, FDA Investigator
- Zakaria I. Ganiyu, FDA Investigator
- Noreen Muniz, FDA Investigator
- Arwa S. El Hagrasy, FDA Investigator
- El Hagrasy, Arwa S, FDA Investigator
- Steven Fong, FDA Investigator
- Sneha S. Patel, FDA Investigator
- Emily J. Orban, FDA Investigator
- Zhihao Pete Qiu, FDA Investigator
- Michele Perry-Williams, FDA Investigator
- Xiaokuang Lai, FDA Investigator
- Michele Perry Williams, FDA Investigator